Suchergebnisse - "Gulick, Roy M"

PubPharm (263)

71

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

enthalten in: The journal of infectious diseases | 2016

von Gulick, R. | Wilkin, T. | Chen, Y. | +26

72

Choosing Initial Antiretroviral Therapy : Current Recommendations for Initial Therapy and Newer or Investigational Agents

enthalten in: Topics in antiviral medicine | 2015

von Gulick, R.

73

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery

enthalten in: AIDS (London, England) | 2015

von Cillo, A. | Hilldorfer, B. | Lalama, C. | +10

74

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

enthalten in: Nature | 2015

von Caskey, M. | Klein, F. | Lorenzi, J. | +22

ErratumIn: Nature. 2016 Jul 28;535(7613):580. - PMID 27007847

75

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols

enthalten in: Pharmacogenetics and genomics | 2015

von Lehmann, D. | Ribaudo, H. | Daar, E. | +6

76

Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols

enthalten in: Open forum infectious diseases | 2015

von Moore, C. | Verma, A. | Pendergrass, S. | +8

77

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery

enthalten in: Aids | 2015

von Cillo, A. | Hilldorfer, B. | Lalama, C. | +10

78

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery

enthalten in: Aids | 2015

von Cillo, A. | Hilldorfer, B. | Lalama, C. | +10

79

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols

enthalten in: Pharmacogenetics and genomics | 2015

von Lehmann, D. | Ribaudo, H. | Daar, E. | +6

80

Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Zheng, Y. | Hughes, M. | Lockman, S. | +10